Researchers – Regional Data
Resources for Regional Data
Here you can find customized resources to help you learn more about regional data for HPV vaccination.
Case Study – Michigan State Health Department Increase Rate Awareness
The Michigan State Health Department identified rate awareness as a tool to increase their national ranking within the National Immunization Survey for vaccination coverage. The State Health Department used their registry, the Michigan Care Improvement Registry (MCIR) to provide county-level report cards and be sure County Health Officials were aware of their Immunization Rates and knew how they compared to other counties in the state.
Case Study - Texas Vaccines for Children
The Texas Immunization Program identified that a strong provider recommendation at Texas Vaccines for Children (TVFC) clinics could lead to increased HPV immunization rates in adolescents. Ideally, providers should be ordering and administering three doses of HPV vaccine for every one dose of Tdap. The goal of this project was to supply TVFC providers with proven strategies for making a strong recommendation, as well as provide them with a profile of their ordering habits for adolescent platform vaccines.
Case Study – Rhode Island Immunization
In 2015, the year the HPV vaccine was required, about 68 percent of girls and 58 percent of boys aged 13 to 17 had received all three doses of the vaccine, up from 56.5 percent and 43.2 percent from 2013. By the end of 2015, the first year it was implemented, 74 percent of seventh graders, including both public and private students, in Rhode Island had received the first dose.
Additional Resources for Researchers
Eliminate HPV Cancers
The National HPV Vaccination Roundtable has put together a summary outlining the possibilities and challenges of eliminating HPV cancers as a public health problem. HPV experts from around the world see a clear path forward to eliminating cancers caused by HPV. The United States can and should be one of the first countries to achieve the elimination of cervical cancer, with other HPV-related cancers in males and females to follow.